title: Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.
authors.forename: H
authors.initials: H
authors.lastname: Paripati
authors.forename: A K
authors.initials: AK
authors.lastname: Stewart
authors.forename: S
authors.initials: S
authors.lastname: Cabou
authors.forename: A
authors.initials: A
authors.lastname: Dueck
authors.forename: V J
authors.initials: VJ
authors.lastname: Zepeda
authors.forename: N
authors.initials: N
authors.lastname: Pirooz
authors.forename: C
authors.initials: C
authors.lastname: Ehlenbeck
authors.forename: C
authors.initials: C
authors.lastname: Reeder
authors.forename: J
authors.initials: J
authors.lastname: Slack
authors.forename: J F
authors.initials: JF
authors.lastname: Leis
authors.forename: J
authors.initials: J
authors.lastname: Boesiger
authors.forename: A S
authors.initials: AS
authors.lastname: Torloni
authors.forename: R
authors.initials: R
authors.lastname: Fonseca
authors.forename: P L
authors.initials: PL
authors.lastname: Bergsagel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D012074:Remission Induction; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide